These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10618548)

  • 1. Immunization with a DNA expression vector encoding the varicella zoster virus glycoprotein E (gE) gene via intramuscular and subcutaneous routes.
    Hasan UA; Harper DR; Argent S; Layton G; Wren BW; Morrow WJ
    Vaccine; 2000 Feb; 18(15):1506-14. PubMed ID: 10618548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with a DNA vaccine expressing a truncated form of varicella zoster virus glycoprotein E.
    Hasan UA; Harper DR; Wren BW; Morrow WJ
    Vaccine; 2002 Jan; 20(9-10):1308-15. PubMed ID: 11818149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential neutralizing antibody responses to varicella-zoster virus glycoproteins B and E following naked DNA immunization.
    Massaer M; Haumont M; Garcia L; Mazzu L; Bollen A; Jacobs P; Jacquet A
    Viral Immunol; 1999; 12(3):227-36. PubMed ID: 10532651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of immune responses to varicella zoster viral proteins induced by DNA vaccination.
    Abendroth A; Slobedman B; Springer ML; Blau HM; Arvin AM
    Antiviral Res; 1999 Dec; 44(3):179-92. PubMed ID: 10651069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization with Varicella-zoster virus glycoprotein E expressing vectors: Comparison of antibody response to DNA vaccine and recombinant vaccinia virus.
    Stasíková J; Kutinová L; Smahel M; Nĕmecková S
    Acta Virol; 2003; 47(1):1-10. PubMed ID: 12828337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of glycoprotein E subunit and live attenuated varicella-zoster virus vaccines formulated with a single-strand RNA-based adjuvant.
    Lee SJ; Park HJ; Ko HL; Lee JE; Lee HJ; Kim H; Nam JH
    Immun Inflamm Dis; 2020 Jun; 8(2):216-227. PubMed ID: 32167678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A DNA immunization model study with constructs expressing the tick-borne encephalitis virus envelope protein E in different physical forms.
    Aberle JH; Aberle SW; Allison SL; Stiasny K; Ecker M; Mandl CW; Berger R; Heinz FX
    J Immunol; 1999 Dec; 163(12):6756-61. PubMed ID: 10586074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA immunization of mice and macaques with plasmids encoding hepatitis C virus envelope E2 protein expressed intracellularly and on the cell surface.
    Forns X; Emerson SU; Tobin GJ; Mushahwar IK; Purcell RH; Bukh J
    Vaccine; 1999 Apr; 17(15-16):1992-2002. PubMed ID: 10217599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterologous Prime-Boost Immunization Strategies Using Varicella-Zoster Virus gE mRNA Vaccine and Adjuvanted Protein Subunit Vaccine Triggered Superior Cell Immune Response in Middle-Aged Mice.
    Li D; Bian L; Cui L; Zhou J; Li G; Zhao X; Xing L; Cui J; Sun B; Jiang C; Kong W; Zhang Y; Chen Y
    Int J Nanomedicine; 2024; 19():8029-8042. PubMed ID: 39130684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenicity of a candidate varicella-zoster virus glycoprotein subunit vaccine.
    Vafai A
    Vaccine; 1993; 11(9):937-40. PubMed ID: 8212841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of a recombinant varicella-zoster virus gE-IE63 fusion protein, a putative vaccine candidate against primary infection and zoster reactivation.
    Jacquet A; Haumont M; Massaer M; Garcia L; Mazzu P; Daminet V; Grégoire D; Jacobs P; Bollen A
    Vaccine; 2002 Feb; 20(11-12):1593-602. PubMed ID: 11858867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inoculation of plasmids encoding Japanese encephalitis virus PrM-E proteins with colloidal gold elicits a protective immune response in BALB/c mice.
    Zhao Z; Wakita T; Yasui K
    J Virol; 2003 Apr; 77(7):4248-60. PubMed ID: 12634382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superiority of intramuscular route and full length glycoprotein D for DNA vaccination against herpes simplex 2. Enhancement of protection by the co-delivery of the GM-CSF gene.
    Fló J; Beatriz Perez A; Tisminetzky S; Baralle F
    Vaccine; 2000 Aug; 18(28):3242-53. PubMed ID: 10869769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of immune responses in ducks with a DNA vaccine encoding duck plague virus glycoprotein C.
    Lian B; Cheng A; Wang M; Zhu D; Luo Q; Jia R; Liu F; Han X; Chen X
    Virol J; 2011 May; 8():214. PubMed ID: 21569289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LNP-CpG ODN-adjuvanted varicella-zoster virus glycoprotein E induced comparable levels of immunity with Shingrix™ in VZV-primed mice.
    Luan N; Cao H; Wang Y; Lin K; Liu C
    Virol Sin; 2022 Oct; 37(5):731-739. PubMed ID: 35671982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA-based and alphavirus-vectored immunisation with prM and E proteins elicits long-lived and protective immunity against the flavivirus, Murray Valley encephalitis virus.
    Colombage G; Hall R; Pavy M; Lobigs M
    Virology; 1998 Oct; 250(1):151-63. PubMed ID: 9770429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant glycoprotein E produced in mammalian cells in large-scale as an antigen for varicella-zoster-virus serology.
    Thomsson E; Persson L; Grahn A; Snäll J; Ekblad M; Brunhage E; Svensson F; Jern C; Hansson GC; Bäckström M; Bergström T
    J Virol Methods; 2011 Jul; 175(1):53-9. PubMed ID: 21540058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmid DNA-expressed secreted and nonsecreted forms of herpes simplex virus glycoprotein D2 induce different types of immune responses.
    Higgins TJ; Herold KM; Arnold RL; McElhiney SP; Shroff KE; Pachuk CJ
    J Infect Dis; 2000 Nov; 182(5):1311-20. PubMed ID: 11023455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with plasmid DNA encoding the envelope glycoprotein of Japanese Encephalitis virus confers significant protection against intracerebral viral challenge without inducing detectable antiviral antibodies.
    Ashok MS; Rangarajan PN
    Vaccine; 1999 Aug; 18(1-2):68-75. PubMed ID: 10501236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of neutralizing antibody and T-cell responses to varicella-zoster virus (VZV) using Ty-virus-like particles carrying fragments of glycoprotein E (gE).
    Garcia-Valcarcel M; Fowler WJ; Harper DR; Jeffries DJ; Layton GT
    Vaccine; 1997; 15(6-7):709-19. PubMed ID: 9178473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.